Medical Device | April 05, 2022
Agilent joins AMBIC to advance biomanufacturing
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences
The award recognizes and supports promising women scientists
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease
Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer
Subscribe To Our Newsletter & Stay Updated
